Covidien
2
18M
2
0.14
1
- Areas of investment
Summary
Covidien is the famous Corporate Investor, which was founded in 2007. The company was established in Europe in Ireland. The main office of represented Corporate Investor is situated in the Dublin.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Covidien, startups are often financed by Delphi Ventures, Alloy Ventures. The meaningful sponsors for the fund in investment in the same round are The Foundry, Solas BioVentures, New Enterprise Associates. In the next rounds fund is usually obtained by Solas BioVentures, New Enterprise Associates, Medtronic.
The important activity for fund was in 2014. The average startup value when the investment from Covidien is 50-100 millions dollars. The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Among the most popular portfolio startups of the fund, we may highlight FIRE1, AEGEA Medical. We can highlight the next thriving fund investment areas, such as Manufacturing, Medical Device. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.14
- Investments by industry
- Biotechnology (2)
- Medical Device (2)
- Health Care (2)
- Therapeutics (1)
- Manufacturing (1)
- Investments by region
-
- United States (1)
- Ireland (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 1.00
- Avg. company exit year
- 14
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| FIRE1 | 09 Jan 2014 | Biotechnology, Health Care, Medical Device, Therapeutics | Early Stage Venture | County Dublin, Dublin, Ireland |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.